I understand that the August 2015 FDA partial hold on the Phase 3 Study for DCVax-L was first disclosed by AVII77, and that NWBO published its 80/21/2015 Form 8-K disclosing the hold in response to this leak by AVII77. Is that true?
Market Data 
Markets 
AI
